Ryman Healthcare Limited

Symbol: RYM.NZ

NZE

3.67

NZD

Market price today

  • 6.7519

    P/E Ratio

  • 0.5176

    PEG Ratio

  • 2.51B

    MRK Cap

  • 0.00%

    DIV Yield

Ryman Healthcare Limited (RYM-NZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.03%

Operating Profit Margin

-0.00%

Net Profit Margin

0.41%

Return on Assets

0.03%

Return on Equity

0.08%

Return on Capital Employed

-0.00%

Company general description and statistics

Sector: Healthcare
Industry: Medical - Care Facilities
CEO:Mr. Richard Umbers
Full-time employees:7200
City:Christchurch
Address:Airport Business Park
IPO:2000-01-04
CIK:

Ryman Healthcare Limited develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly in New Zealand and Australia. The company's villages provide a range of retirement living and care options, such as independent townhouses and apartments, and serviced apartments, as well as a care center, which offers rest homes, hospitals, dementia-level care, and respite and day care services. Its villages also provide all-weather bowling green, indoor heated swimming pool and spa, gym, internal atrium, beauty and hairdressing salons, library, dining room, internet café, bar, lounges, croquet laws, shops, and movie theatre facilities. As of May 20, 2022, Ryman Healthcare Limited owned and operated 45 retirement villages with approximately 8,538 retirement village units and 4,239 care units. The company was founded in 1984 and is based in Christchurch, New Zealand.

General Outlook

When we look at how much money they make before expenses, they keep 0.026% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.001%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.411%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.029% return, is a testament to Ryman Healthcare Limited's adeptness in optimizing resource deployment. Ryman Healthcare Limited's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.079%. Furthermore, the proficiency of Ryman Healthcare Limited in capital utilization is underscored by a remarkable -0.000% return on capital employed.

Stock Prices

Ryman Healthcare Limited's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $4.1, while its low point bottomed out at $4.01. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Ryman Healthcare Limited's stock market.

Liquidity Ratios

Analyzing RYM.NZ liquidity ratios reveals its financial health of the firm. The current ratio of 363.84% gauges short-term asset coverage for liabilities. The quick ratio (359.69%) assesses immediate liquidity, while the cash ratio (16.54%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio363.84%
Quick Ratio359.69%
Cash Ratio16.54%

Profitability Ratios

RYM.NZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 21.69% underscores its earnings before tax deductions. The effective tax rate stands at -29.78%, revealing its tax efficiency. The net income per EBT, 189.33%, and the EBT per EBIT, -20090.44%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -0.11%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin21.69%
Effective Tax Rate-29.78%
Net Income per EBT189.33%
EBT per EBIT-20090.44%
EBIT per Revenue-0.11%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 3.64, it details the span from stock purchase to revenue. The 4 days it takes to settle debts showcases its creditor relations.

cards.indicatorcards.value
Days of Sales Outstanding360
Days of Inventory Outstanding3
Operating Cycle278.87
Days of Payables Outstanding51
Cash Conversion Cycle228
Receivables Turnover1.33
Payables Turnover7.14
Inventory Turnover106.74
Fixed Asset Turnover0.41
Asset Turnover0.07

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 1.45, and free cash flow per share, 0.81, depict cash generation on a per-share basis. The cash per share value, 0.05, showcases liquidity position. Lastly, the operating cash flow sales ratio, 1.09, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share1.45
Free Cash Flow per Share0.81
Cash per Share0.05
Operating Cash Flow Sales Ratio1.09
Free Cash Flow to Operating Cash Flow Ratio0.56
Cash Flow Coverage Ratio0.40
Capital Expenditure Coverage Ratio2.26
Dividend Paid and Capex Coverage Ratio2.26
Dividend Payout Ratio0.03

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 19.10%, highlights its total liabilities relative to assets. With a debt-equity ratio of 0.51, we discern the balance between debt and equity financing. The long-term debt to capitalization, 33.95%, and total debt to capitalization, 33.95%, ratios shed light on its capital structure.

cards.indicatorcards.value
Debt Ratio19.10%
Debt Equity Ratio0.51
Long Term Debt to Capitalization33.95%
Total Debt to Capitalization33.95%
Cash Flow to Debt Ratio0.40
Company Equity Multiplier2.69

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.08, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.50, reflects the portion of profit attributed to each share. The book value per share, 9.03, represents the net asset value distributed per share, while the tangible book value per share, 8.87, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.08
Net Income Per Share0.50
Book Value Per Share9.03
Tangible Book Value Per Share8.87
Shareholders Equity Per Share9.03
Interest Debt Per Share4.94
Capex Per Share-0.63

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, 11.35%, indicates top-line expansion, while the gross profit growth, 11.35%, reveals profitability trends. EBIT growth, 75.11%, and operating income growth, 75.11%, offer insights into operational profitability progression. The net income growth, 63.78%, showcases bottom-line expansion, and the EPS growth, 63.75%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth11.35%
Gross Profit Growth11.35%
EBIT Growth75.11%
Operating Income Growth75.11%
Net Income Growth63.78%
EPS Growth63.75%
EPS Diluted Growth63.75%
Dividends per Share Growth4.19%
Free Cash Flow Growth287.85%
10-Year Revenue Growth per Share179.29%
5-Year Revenue Growth per Share47.92%
3-Year Revenue Growth per Share32.23%
10-Year Operating CF Growth per Share227.86%
5-Year Operating CF Growth per Share78.22%
3-Year Operating CF Growth per Share108.68%
10-Year Net Income Growth per Share406.75%
5-Year Net Income Growth per Share78.48%
3-Year Net Income Growth per Share161.74%
10-Year Shareholders Equity Growth per Share367.62%
5-Year Shareholders Equity Growth per Share76.99%
3-Year Shareholders Equity Growth per Share58.26%
10-Year Dividend per Share Growth per Share146.15%
5-Year Dividend per Share Growth per Share19.15%
3-Year Dividend per Share Growth per Share3.22%
Receivables Growth24.00%
Inventory Growth-1.59%
Asset Growth19.57%
Book Value per Share Growth21.39%
Debt Growth13.21%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 5,027,553,750, captures the company's total value, considering both debt and equity. Income quality, 2.11, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 0.68%, indicates the value of non-physical assets, and capex to operating cash flow, -59.73%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value5,027,553,750
Income Quality2.11
Research and Development to Revenue2.10%
Intangibles to Total Assets0.68%
Capex to Operating Cash Flow-59.73%
Capex to Revenue-57.88%
Capex to Depreciation-695.77%
Graham Number10.07
Return on Tangible Assets2.08%
Graham Net Net-13.99
Working Capital328,801,000
Tangible Asset Value4,579,065,000
Net Current Asset Value-7,039,513,000
Invested Capital1
Average Receivables710,108,000
Average Payables93,658,500
Average Inventory20,465,000
Days Sales Outstanding478
Days Payables Outstanding68
Days of Inventory On Hand9
ROIC7.54%
ROE0.06%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 0.52, and the price to book ratio, 0.52, reflect the market's valuation relative to the company's book value. The price to sales ratio, 2.76, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 4.55, and price to operating cash flows, 2.54, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio0.52
Price to Book Ratio0.52
Price to Sales Ratio2.76
Price Cash Flow Ratio2.54
Price Earnings to Growth Ratio0.52
Enterprise Value Multiple0.72
Price Fair Value0.52
Price to Operating Cash Flow Ratio2.54
Price to Free Cash Flows Ratio4.55
Price to Tangible Book Ratio0.58
Enterprise Value to Sales8.98
Enterprise Value Over EBITDA10.72
EV to Operating Cash Flow9.26
Earnings Yield9.51%
Free Cash Flow Yield8.06%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Ryman Healthcare Limited (RYM.NZ) on the NZE in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 6.752 in 2024.

What is the ticker symbol of Ryman Healthcare Limited stock?

The ticker symbol of Ryman Healthcare Limited stock is RYM.NZ.

What is company IPO date?

IPO date of Ryman Healthcare Limited is 2000-01-04.

What is company current share price?

Current share price is 3.670 NZD.

What is stock market cap today?

The market cap of stock today is 2514492125.000.

What is PEG ratio in 2024?

The current 0.518 is 0.518 in 2024.

What is the number of employees in 2024?

In 2024 the company has 7200.